Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sequana Medical presented its investor deck in February 2022 detailing innovations in treating diuretic-resistant fluid overload. The presentation covers the alfapump® system for refractory ascites and DSR® therapy, both addressing critical unmet needs in fluid management.
conference
21 Pages
investor_presentation
38 Pages
Societe Generale
Teva Pharmaceutical 2016-2019 Financial Outlook
investor_presentationinvestor_presentation
21 Pages
Teva Pharmaceutical Industries